OpenAI is offering up to $445K for an AI safety role in 2026 focused on self-improving systems. Here’s why it’s raising concern across the industry.
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results